Gastric ulcer: is endoscopy always necessary?
Comment
This prospective study was undertaken to establish whether analysis of the guideline pattem around a gastric ulcer as shown by doublecontrast barium-meal examination performed by experienced radiologists permitted an accurate prediction of whether the lesion was benign or malignant. Using this criterion confident radiological diagnosis of a benign ulcer was not disproved by either endoscopic biopsy or subsequent operation with histological examination of the resected specimen.
It might be argued that some of the lesions diagnosed as benign both radiologically and endoscopically may subsequently prove to be malignant, but this was not observed during the period of the study, the longest follow-up being four years.
Although mindful of the need to diagnose gastric cancer as early as possible, we nevertheless think that when apatient has been investigated with double-contrast barium-meal examination the more invasive and time-consuming technique of endoscopy may be reserved for patients in whom radiological assessment of whether a gastric ulcer is present is equivocal; the guideline pattern around the ulcer is not adequately shown; or the guideline pattem around the ulcer crater suggests malignancy.
The need for careful follow-up remains, however, with these two diagnostic techniques being complementary rather than mutually exclusive. 
Both patients showed hyperoxaluria that was clearly metabolic in origin since urinary glycollate excretion was also raised. The known causes for raised excretion of these acids are primary hyperoxaluria, pyridoxine deficiency, excess glycine load, and ethylene glycol intoxication. None of these fits the facts in these cases. The last two are obviously excluded, and there was no other evidence of pyridoxine deficiency (anaemia, convulsions). Nevertheless, some young women apparently exist on a low pyridoxine intake and show subclinical pyridoxine deficiency.3 So simple an explanation for hyperoxaluria seems unlikely in the second case, however, because of the finding of renal tubular acidosis, which has been described before in combination with hyperoxaluria.4 Primary hyperoxaluria is excluded by four facts. Firstly, in this condition urinary oxalate excretion is considerably higher than in these cases. Secondly, urinary glycollate excretion in primary hyperoxaluria is lower than urinary oxalate excretion. Thirdly, in primary hyperoxaluria the response to pyridoxine lasts only as long as the vitamin is given and immediately relapses on stopping it. These two patients did not relapse even after long periods of time. Fourthly, primary hyperoxaluria requires high doses of pyridoxine whereas in case 2 a remarkably low dose was effective.
It seems necessary to postulate a new cause of hyperoxaluria. There may have been a slightly increased requirement for pyridoxine, possibly induced by extraneous factors. The 
Eosinophilia in patients undergoing dialysis
Over the past few years, many of our patients on maintenance haemodialysis have developed eosinophilia without apparent reason. To our knowledge, the published reports contain little information on the subject,' and major textbooks on dialysis do not even mention it.2
We report our experience with this phenomenon.
Patients, methods, and results
Nineteen (25 %) out of 77 uraemic patients undergoing dialysis for 18 hours weekly with deionised water, RSP artificial kidneys, cuprophan coils, and polyvinylchloride tubing (all from Travenol Laboratories, Deerfield, Illinois) developed eosinophilia (> 500 eosinophils/mm3). Dialysers were not reused. Mean number of eosinophils per mm3 was 1391 ±(SEM) 319; (range 500 to 9028). Eosinophilia appeared after an average of 20±3 months of haemodialysis (range two to 35 months), and once it had appeared persisted in all patients but two, in whom the number of eosinophils returned to normal after having remained raised for six and 72 months. No cause for eosinophilia other than haemodialysis could be found in any patient. 
Comment
This study shows that about 2500°of those undergoing haemodialysis develop eosinophilia. It seems logical to assume that the raised eosinophil count is a consequence of the dialysis procedure per se if one considers that: (a) eosinophilia was not present before the start of haemodialysis and was therefore not due simply to renal failure, (b) there was little association with the diseases responsible for renal failure, (c) there was no obvious relation to any medication, (d) other causes of eosinophilia were not apparent, and (e) eosinophilia tended to persist once it had appeared, suggesting that it was somehow maintained by repetitive dialysis.
Patients undergoing haemodialysis are subject to many substances that may invoke hypersensitivity, such as heparin, plasticisers from tubing,3 particles of rubber from stoppers, etc. Any one of these substances, or a combination of them, could lead to the development of eosinophilia, and further studies are clearly needed to determine its causes.
Although serious cutaneous hypersensitivity3 and anaphylactic reactions' have been associated with eosinophilia in patients undergoing dialysis, our experience appears to show that eosinophilia in patients undergoing dialysis is a benign laboratory abnormality that does not necessarily result in increased morbidity. Contrary to previous reports,' reuse of dialysers did not seem to be implicated. 
